Company: HCTI
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112544
Chunk: 22

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 22
---
This offering of common stock pursuant to this
prospectus supplement will terminate upon the earlier of (i) the sale of all common stock provided for in this prospectus supplement,
or (ii) termination of the ATM Sales Agreement as permitted therein.

This summary of the material provisions of the
ATM Sales Agreement does not purport to be a complete statement of its terms and conditions. A copy of the ATM Sales Agreement is included
as an exhibit to our Current Report on Form 8-K that will be filed with the SEC and incorporated by reference into the registration statement
of which this prospectus supplement and the accompanying base prospectus form a part. See “Where You Can Find Additional Information”
and “Incorporation of Documents By Reference” below.

The Sales Agent and its affiliates may in the
future provide various investment banking, commercial banking and other financial services for us and our affiliates, for which services
they may in the future receive customary fees. Previously, on February 27, 2025, we engaged the Sales Agent as a co-placement agent in
our February 28, 2025, $15.2 million PIPE offering. Pursuant to the placement agent agreement, at the conclusion of our PIPE offering, we
paid the Sales Agent a placement fee of $554,000.

In addition, in the ordinary course of its various
business activities, The Sales Agent and its affiliates may make or hold a broad array of investments and actively trade debt and equity
securities (or related derivative securities) and financial instruments (which may include bank loans) for their own account and for the
accounts of their customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates.
The Sales Agent or its affiliates may also make investment recommendations and/or publish or express independent research views in respect
of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such
securities and instruments. To the extent required by Regulation M under the Exchange Act, the Sales Agent will not engage in any market
making activities involving our common stock while the offering is ongoing under this prospectus supplement. Moreover, the Sales Agent
will not engage in any transactions that stabilizes our common stock.

This prospectus supplement and the accompanying
base prospectus in electronic format may be made available on a website maintained by the Sales Agent and the Sales Agent may distribute
this prospectus supplement and the accompanying base prospectus

<div align='center'>S-